Held on 30 September 2014
Socrus Bio Sciences announced that the Board of Directors of the Company at its meeting held on 30 September 2014, has discussed and took into consideration the following:1. Reduction of Capital of the Company to the extent of 95% of paid up capital against accumulated losses under Section 100 of the Companies Act, 1956.
2. Recommend the scheme of reduction for the consideration of the Audit Committee to be held on 10 October 2014, and
3. Appointed Valuer and Merchant Banker as per Clause 24(f) & 24(h) of the Listing Agreement.
The Board Meeting of the Company scheduled to be held on 14 October 2014 to consider the Reduction of Capital based on the recommendation of Audit Committee.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app